Safety profile of Infanrix hexa – 17 years of GSK’s passive post-marketing surveillance-Reference-Cited by-同舟云学术

Safety profile of Infanrix hexa – 17 years of GSK’s passive post-marketing surveillance

Published:2020-08-02 Issue:8 Volume:19 Page:771-779
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Puente Gómez Ivonne¹²,Verheust Céline¹,Hanssens Linda¹³,Dolhain Jan¹⁴^ORCID

Affiliation:

1. GSK, Wavre, Belgium

2. AstraZeneca, Mölndal, Sweden

3. Miltenyi Biomedicine, Bergisch Gladbach, North Rhine-Westphalia, Germany

4. Danone Benelux, Belgium

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2020.1800458

Reference47 articles.

1. Hexavalent vaccines for immunization in paediatric age

2. Review of 8 years of experience with Infanrix hexa™ (DTPa–HBV–IPV/Hib hexavalent vaccine)

3. European Medicines Agency. Infanrix hexa product information. [Cited 2018 Oct 16]. Available from: https://www.ema.europa.eu/documents/product-information/infanrix-hexa-epar-product-information_en.pdf

4. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines

5. Extensive Swelling After Booster Doses of Acellular Pertussis–Tetanus–Diphtheria Vaccines

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure;Expert Review of Vaccines;2023-12-06

2. Combination Vaccines;Plotkin's Vaccines;2023

3. Collection, compilation and analysis of bacterial vaccines;Computers in Biology and Medicine;2022-10

4. Hexavalent vaccines: What can we learn from head-to-head studies?;Vaccine;2021-10

5. How were DTP-related adverse events reduced after the introduction of an acellular pertussis vaccine in Chile?;Human Vaccines & Immunotherapeutics;2021-09-08